Abstract:Background and Purpose: Once a stroke occurs in a patient with atrial fibrillation (AF), it is likely to be severe. Patients with newly diagnosed AF after stroke and those with known AF before stroke have different background characteristics, yet the difference in stroke severity has not been sufficiently evaluated. In the current study, we compared the stroke severity and in-hospital outcomes between these patient groups. Methods: We retrospectively analyzed a database of 196 patients with acute ischemic stroke and AF between January 2010 and October 2019. We divided the patients into two groups: patients with “newly diagnosed AF” and those with “known AF.” We assessed the stroke severity using the National Institutes of Health Stroke Scale (NIHSS) score on admission and in-hospital outcomes using the modified Rankin Scale (mRS) score at discharge. Results: The proportion of newly diagnosed AF was 33% (64/196). There were no differences in age, hypertension, diabetes mellitus, and past history of heart failure between patients with newly diagnosed AF and those with known AF. Patients with newly diagnosed AF were associated with a lower proportion of male sex (male; 50 vs. 67%, p < 0.05), a lower proportion of past history of stroke (12 vs. 35%, p < 0.01), a lower CHA 2 DS 2 -VASc score (median [interquartile range]; 3 [2–4] vs. 3.5 [3–5], p < 0.01), and a lower proportion of pre-stroke oral anticoagulation (5 vs. 59%, p < 0.01). There were no differences in the NIHSS score on admission (12 [4–19] vs. 9 [3–19]) or the mRS score at discharge (3 [1–5] vs. 3 [1–5]). After adjustment for relevant covariates, newly diagnosed AF was not associated with the NIHSS score on admission [adjusted common odds ratio (OR), 0.85; 95% confidence interval (CI), 0.45–1.60] or the mRS score at discharge (adjusted common OR, 1.67; 95% CI, 0.88–3.18). After propensity score matching, newly diagnosed AF was not associated with the NIHSS score on admission (adjusted common OR, 0.91; 95% CI, 0.48–1.73) and the mRS score at discharge (adjusted common OR, 1.77; 95% CI, 0.92–3.43). Conclusion: Stroke severity and in-hospital outcomes in patients with newly diagnosed AF did not differ from those in patients with known AF after adjustment for clinically relevant factors. The importance of detection of latent AF and subsequent anticoagulation in preventing severe stroke should be further emphasized.

Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation

Impact of Atrial Fibrillation on Clinical Outcome in Patients with Acute Ischemic Stroke Undergoing Thrombolytic Therapy

Undertreatment of Anticoagulant Therapy in Hospitalized Acute Ischemic Stroke Patients with Atrial Fibrillation

[Association of Atrial Fibrillation with Hemorrhagic Transformation after Intravenous Thrombolysis in Patients with Ischemic Stroke].

Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation

Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke

Contemporary outcomes of acute ischemic stroke in atrial fibrillation patients on anticoagulation

A Retrospective Study on Patients with Stroke and Non-Rheumatic Atrial Fibrillation Treated with Anticoagulation

Anticoagulation Therapy After Reperfusion Treatment for Non-Valvular Atrial Fibrillation-Related Acute Ischemic Stroke—A Multicenter Retrospective Study

Oral Anticoagulant Use in Atrial Fibrillation-Associated Ischemic Stroke: A Retrospective, Multicenter Survey in Northwestern China

Factors Associated with Thrombolysis Outcome in Ischemic Stroke Patients with Atrial Fibrillation

Anticoagulation Usage and Thrombolytic Therapy in Subjects with Atrial Fibrillation Associated Ischaemic Stroke.

Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome

Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation

An In-Depth Analysis of the Clinical Outcome of Ischemic Stroke Patients with Atrial Fibrillation

Oral anti-coagulants use in Chinese hospitalized patients with atrial fibrillation

Anticoagulation therapy in non-valvular atrial fibrillation after intracerebral hemorrhage: A propensity score–matched study

Abstract TP163: Associations Between Prior Oral Anticoagulant Use and Stroke Outcomes in a National Stroke Cohort: A Scottish Database Study

Abstract TP269: Determining Differences in the Association Between Atrial Fibrillation and Ischemic Stroke Outcomes by Acute Therapy Received

Clinical Investigation of the Treatment of Acute Stroke with Atrial Fibrillation: Gap Between Guidelines and Practice

Early vs Late Anticoagulation in Acute Ischemic Stroke with Indications Outside Atrial Fibrillation